Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review

Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review

ABSTRACT: Objectives: Dalbavancin is a long-lasting lipoglycopeptide active against Gram-positive bacteria, especially methicillin-resistant staphylococci. Few data are available on dalbavancin use for treatment of prosthetic joint infections (PJIs). We describe a cohort of patients treated for PJI...

Full description

Bibliographic Details
Main Authors: Morgan Matt, Clara Duran, Johan Courjon, Romain Lotte, Vincent Le Moing, Boris Monnin, Patricia Pavese, Pascal Chavanet, Lydie Khatchatourian, Pierre Tattevin, Vincent Cattoir, Catherine Lechiche, Gabriella Illes, Flore Lacassin-Beller, Eric Senneville, Aurélien Dinh
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Dalbavancin
Prosthetic joint infection
PJI
Staphylococci
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716521000989

Internet

http://www.sciencedirect.com/science/article/pii/S2213716521000989

Similar Items